InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,835.60
(
0.99%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.63
(
-0.80%
)
Bitcoin
56,416.54
(
-0.99%
)
Post# of 91007
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Traderboy1966

Send PM Follow Ignore
Followers 39
Posts 1575
Boards Moderated 0
Alias Born 02/26/2013

Traderboy1966

Re: None

Saturday, 06/29/2013 6:07:55 PM

Saturday, June 29, 2013 6:07:55 PM

Post# of 91007

The Future
Once the FDA agrees with IntelliCell that it falls under either CFR 1271.15(b) or
PHS 361: CFR 1271.10 (a), the business model can be supplemented with
placing the IntelliCell Labs into other surgical centers and/or hospitals. This
would be a modified franchise model where IntelliCell would operate the labs.
The revenue stream would flow from IntelliCell licensing and/or selling the
“IntelliCell” process to the hospital or doctors for use with their patients.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up